137 related articles for article (PubMed ID: 1853781)
1. Design of clinical therapeutic trials in amyotrophic lateral sclerosis.
Brooks BR; Sufit RL; DePaul R; Tan YD; Sanjak M; Robbins J
Adv Neurol; 1991; 56():521-46. PubMed ID: 1853781
[No Abstract] [Full Text] [Related]
2. Clinical trials in ALS: measurement and natural history.
Munsat TL; Hollander D; Andres P; Finison L
Adv Neurol; 1991; 56():515-9. PubMed ID: 1853780
[No Abstract] [Full Text] [Related]
3. Issues in amyotrophic lateral sclerosis clinical trial design.
Munsat TL
Adv Neurol; 1995; 68():209-18. PubMed ID: 8787231
[No Abstract] [Full Text] [Related]
4. Megaslope, natural course, and historical controls in amyotrophic lateral sclerosis trials.
Conradi S; Ronnevi LO
Adv Neurol; 1995; 68():219-24. PubMed ID: 8787232
[No Abstract] [Full Text] [Related]
5. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis.
Bromberg MB; Forshew DA; Nau KL; Bromberg J; Simmons Z; Fries TJ
Muscle Nerve; 1993 Nov; 16(11):1213-9. PubMed ID: 8413373
[TBL] [Abstract][Full Text] [Related]
6. The design of clinical trials in amyotrophic lateral sclerosis.
Azulay JP
Adv Neurol; 1995; 68():225-7. PubMed ID: 8787233
[No Abstract] [Full Text] [Related]
7. Reinnervation cannot be interpreted as an indicator of electrophysiologic improvement in amyothrophic lateral sclerosis.
Bek S; Kasikci T; Odabasi Z
Cytotherapy; 2009; 11(2):256-7; author reply 258. PubMed ID: 19191057
[TBL] [Abstract][Full Text] [Related]
8. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors.
J Neurol Sci; 1995 May; 129 Suppl():1-10. PubMed ID: 7595596
[No Abstract] [Full Text] [Related]
9. ALS combination treatment. Drug cocktails.
Rosenfeld J
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():115-7. PubMed ID: 15512890
[No Abstract] [Full Text] [Related]
10. Motor unit estimates in the biceps-brachialis in amyotrophic lateral sclerosis.
Strong MJ; Brown WF; Hudson AJ; Snow R
Muscle Nerve; 1988 May; 11(5):415-22. PubMed ID: 3374513
[TBL] [Abstract][Full Text] [Related]
11. Muscle as a therapeutic target in amyotrophic lateral sclerosis.
Shefner JM
Exp Neurol; 2009 Oct; 219(2):373-5. PubMed ID: 19559701
[No Abstract] [Full Text] [Related]
12. Recent advances in the therapy of amyotrophic lateral sclerosis: focus on excitotoxicity.
Brighina L; Sala G; Ceresa C; Tremolizzo L; Ferrarese C
Funct Neurol; 2001; 16(4 Suppl):189-202. PubMed ID: 11996516
[No Abstract] [Full Text] [Related]
13. [Neuropathology of classical and several other types of amyotrophic lateral sclerosis].
Nakano I
No To Shinkei; 1992 Jun; 44(6):495-503. PubMed ID: 1389558
[No Abstract] [Full Text] [Related]
14. Abnormal motor nerve excitability in amyotrophic lateral sclerosis.
Brown JC; Johns RJ
Johns Hopkins Med J; 1970 Jul; 127(1):55-63. PubMed ID: 5471480
[No Abstract] [Full Text] [Related]
15. Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials.
de Carvalho M; Chio A; Dengler R; Hecht M; Weber M; Swash M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):17-28. PubMed ID: 16036422
[TBL] [Abstract][Full Text] [Related]
16. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
17. Endpoint considerations for clinical trials.
Walton MK
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S3-6. PubMed ID: 12396791
[No Abstract] [Full Text] [Related]
18. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials.
Kelly JJ; Thibodeau L; Andres PL; Finison LJ
Muscle Nerve; 1990 Jun; 13(6):471-9. PubMed ID: 2195338
[TBL] [Abstract][Full Text] [Related]
19. Designing clinical trials in amyotrophic lateral sclerosis.
Shefner JM
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and electromyographic analysis of cases of amyotrophic lateral sclerosis].
Dylewska D; Maksymowicz B
Pol Tyg Lek; 1969 Sep; 24(35):1349-52. PubMed ID: 5348235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
